Tapewire

Nasdaq · USD

KNSA

Kiniksa Pharmaceuticals International, plc

Export transactions ↓
Tapewire entity
1954
SEC CIK
0001730430
Parsed reports
378

Last 12 months

Inside the activity.

0 purchase rows · 37 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202504
Dec 202503
Jan 202601
Feb 202607
Mar 202605
Apr 2026012
May 202603
Jun 202600
Jul 202601
Aug 202600
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
April 01, 2026 Filed Apr 3, 2026 20:35 UTC
Moat RossCHIEF OPERATING OFFICER
Exercise / conversionClass A Ordinary Share 5,808 Not disclosed Not disclosed
Disclosure

SEC source: 0001857177-26-000002 · form4-04032026_080450.xml · nonDerivative · entry 2

Moat Ross · CIK 0001857177 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,102

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:34 UTC
Megna Michael RCHIEF ACCOUNTING OFFICER
Exercise / conversionRestricted Share Unit · Derivative 2,644 $0.00 $0.00
Disclosure

SEC source: 0001464583-26-000002 · form4-04032026_080430.xml · derivative · entry 9

Megna Michael R · CIK 0001464583 · CHIEF ACCOUNTING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,931

Underlying: Class A Ordinary Share · 2,644 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.

F9 · derivative.exercise_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, April 1, 2025.

F9 · derivative.expiration_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, April 1, 2025.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:34 UTC
Megna Michael RCHIEF ACCOUNTING OFFICER
Exercise / conversionRestricted Share Unit · Derivative 2,362 $0.00 $0.00
Disclosure

SEC source: 0001464583-26-000002 · form4-04032026_080430.xml · derivative · entry 8

Megna Michael R · CIK 0001464583 · CHIEF ACCOUNTING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,725

Underlying: Class A Ordinary Share · 2,362 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.

F8 · derivative.exercise_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, April 1, 2024.

F8 · derivative.expiration_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, April 1, 2024.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:34 UTC
Megna Michael RCHIEF ACCOUNTING OFFICER
Exercise / conversionRestricted Share Unit · Derivative 2,558 $0.00 $0.00
Disclosure

SEC source: 0001464583-26-000002 · form4-04032026_080430.xml · derivative · entry 7

Megna Michael R · CIK 0001464583 · CHIEF ACCOUNTING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,557

Underlying: Class A Ordinary Share · 2,558 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.

F7 · derivative.exercise_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, April 1, 2023.

F7 · derivative.expiration_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, April 1, 2023.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:34 UTC
Megna Michael RCHIEF ACCOUNTING OFFICER
GrantPerformance Share Unit · Derivative 7,300 $0.00 $0.00
Disclosure

SEC source: 0001464583-26-000002 · form4-04032026_080430.xml · derivative · entry 6

Megna Michael R · CIK 0001464583 · CHIEF ACCOUNTING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,300

Underlying: Class A Ordinary Share · 73,000 shares

Expires not disclosed

F5 · derivative.exercise_price: Each Performance Share Unit (PSU) represents a contingent right to receive a number of Class A Ordinary Shares of the Issuer based upon the achievement of certain pre-established performance criteria, as certified by the Issuer's Compensation Committee.

F6 · derivative.exercise_date: Unless earlier forfeited, each PSU vests and converts into not more than 200% of one Class A Ordinary Share of the Issuer no later than January 30, 2029, unless such date falls on a non-business date, in which case the next business date shall apply.

F6 · derivative.expiration_date: Unless earlier forfeited, each PSU vests and converts into not more than 200% of one Class A Ordinary Share of the Issuer no later than January 30, 2029, unless such date falls on a non-business date, in which case the next business date shall apply.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:34 UTC
Megna Michael RCHIEF ACCOUNTING OFFICER
GrantRestricted Share Unit · Derivative 3,650 $0.00 $0.00
Disclosure

SEC source: 0001464583-26-000002 · form4-04032026_080430.xml · derivative · entry 5

Megna Michael R · CIK 0001464583 · CHIEF ACCOUNTING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,650

Underlying: Class A Ordinary Share · 3,650 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.

F4 · derivative.exercise_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on the vesting commencement date of April 1, 2026, and each yearly anniversary thereafter.

F4 · derivative.expiration_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on the vesting commencement date of April 1, 2026, and each yearly anniversary thereafter.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:34 UTC
Megna Michael RCHIEF ACCOUNTING OFFICER
GrantShare Option · Derivative 14,600 $0.00 Strike: $48.13 $0.00
Disclosure

SEC source: 0001464583-26-000002 · form4-04032026_080430.xml · derivative · entry 4

Megna Michael R · CIK 0001464583 · CHIEF ACCOUNTING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,600

Underlying: Class A Ordinary Share · 14,600 shares

Expires 2036-03-31

F3 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is April 1, 2026.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:34 UTC
Megna Michael RCHIEF ACCOUNTING OFFICER
Tax withholdingClass A Ordinary Share 3,205 $48.13 $154,256.65
Disclosure

SEC source: 0001464583-26-000002 · form4-04032026_080430.xml · nonDerivative · entry 3

Megna Michael R · CIK 0001464583 · CHIEF ACCOUNTING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,777

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:34 UTC
Megna Michael RCHIEF ACCOUNTING OFFICER
Exercise / conversionClass A Ordinary Share 7,564 Not disclosed Not disclosed
Disclosure

SEC source: 0001464583-26-000002 · form4-04032026_080430.xml · nonDerivative · entry 2

Megna Michael R · CIK 0001464583 · CHIEF ACCOUNTING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,982

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.

Read SEC document
March 09, 2026 Filed Mar 11, 2026 20:38 UTC
Ragosa MarkCHIEF FINANCIAL OFFICER
Exercise / conversionShare Option · Derivative 10,360 $0.00 Strike: $26.74 $0.00
Disclosure

SEC source: 0001835458-26-000006 · form4-03112026_080357.xml · derivative · entry 10

Ragosa Mark · CIK 0001835458 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,790

Underlying: Class A Ordinary Share · 10,360 shares

Expires 2034-08-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on August 14, 2025.

F7 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2024.

Read SEC document
March 09, 2026 Filed Mar 11, 2026 20:38 UTC
Ragosa MarkCHIEF FINANCIAL OFFICER
Exercise / conversionShare Option · Derivative 13,813 $0.00 Strike: $18.06 $0.00
Disclosure

SEC source: 0001835458-26-000006 · form4-03112026_080357.xml · derivative · entry 9

Ragosa Mark · CIK 0001835458 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 19,337

Underlying: Class A Ordinary Share · 13,813 shares

Expires 2034-03-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on August 14, 2025.

F6 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is April 1, 2024.

Read SEC document
March 09, 2026 Filed Mar 11, 2026 20:38 UTC
Ragosa MarkCHIEF FINANCIAL OFFICER
Exercise / conversionShare Option · Derivative 10,513 $0.00 Strike: $17.76 $0.00
Disclosure

SEC source: 0001835458-26-000006 · form4-03112026_080357.xml · derivative · entry 8

Ragosa Mark · CIK 0001835458 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 18,396

Underlying: Class A Ordinary Share · 10,513 shares

Expires 2033-08-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on August 14, 2025.

F5 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2023.

Read SEC document
March 09, 2026 Filed Mar 11, 2026 20:38 UTC
Ragosa MarkCHIEF FINANCIAL OFFICER
Exercise / conversionShare Option · Derivative 2,036 $0.00 Strike: $22.89 $0.00
Disclosure

SEC source: 0001835458-26-000006 · form4-03112026_080357.xml · derivative · entry 7

Ragosa Mark · CIK 0001835458 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Ordinary Share · 2,036 shares

Expires 2031-03-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on August 14, 2025.

F4 · derivative.exercise_date: The option is fully vested and exercisable.

Read SEC document
March 09, 2026 Filed Mar 11, 2026 20:38 UTC
Ragosa MarkCHIEF FINANCIAL OFFICER
SaleClass A Ordinary Share 18,741 $46.24 $866,583.84
Disclosure

SEC source: 0001835458-26-000006 · form4-03112026_080357.xml · nonDerivative · entry 6

Ragosa Mark · CIK 0001835458 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,086

F1 · kind: This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on August 14, 2025.

F3 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging between $45.89 and $46.79. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff fullinformation regarding the number of Shares sold at each price.

Read SEC document
March 09, 2026 Filed Mar 11, 2026 20:38 UTC
Ragosa MarkCHIEF FINANCIAL OFFICER
SaleClass A Ordinary Share 17,981 $45.58 $819,573.98
Disclosure

SEC source: 0001835458-26-000006 · form4-03112026_080357.xml · nonDerivative · entry 5

Ragosa Mark · CIK 0001835458 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 30,827

F1 · kind: This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on August 14, 2025.

F2 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging between $44.885 and $45.88. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.

Read SEC document
March 09, 2026 Filed Mar 11, 2026 20:38 UTC
Ragosa MarkCHIEF FINANCIAL OFFICER
Exercise / conversionClass A Ordinary Share 10,360 $26.74 $277,026.40
Disclosure

SEC source: 0001835458-26-000006 · form4-03112026_080357.xml · nonDerivative · entry 4

Ragosa Mark · CIK 0001835458 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 48,808

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on August 14, 2025.

Read SEC document
March 09, 2026 Filed Mar 11, 2026 20:38 UTC
Ragosa MarkCHIEF FINANCIAL OFFICER
Exercise / conversionClass A Ordinary Share 13,813 $18.06 $249,462.78
Disclosure

SEC source: 0001835458-26-000006 · form4-03112026_080357.xml · nonDerivative · entry 3

Ragosa Mark · CIK 0001835458 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 38,448

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on August 14, 2025.

Read SEC document
March 09, 2026 Filed Mar 11, 2026 20:38 UTC
Ragosa MarkCHIEF FINANCIAL OFFICER
Exercise / conversionClass A Ordinary Share 10,513 $17.76 $186,710.88
Disclosure

SEC source: 0001835458-26-000006 · form4-03112026_080357.xml · nonDerivative · entry 2

Ragosa Mark · CIK 0001835458 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 24,635

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on August 14, 2025.

Read SEC document
March 09, 2026 Filed Mar 11, 2026 20:38 UTC
Ragosa MarkCHIEF FINANCIAL OFFICER
Exercise / conversionClass A Ordinary Share 2,036 $22.89 $46,604.04
Disclosure

SEC source: 0001835458-26-000006 · form4-03112026_080357.xml · nonDerivative · entry 1

Ragosa Mark · CIK 0001835458 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,122

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on August 14, 2025.

Read SEC document
March 02, 2026 Filed Mar 4, 2026 21:40 UTC
Paolini John F.CHIEF MEDICAL OFFICER
Exercise / conversionShare Option · Derivative 40,000 $0.00 Strike: $10.36 $0.00
Disclosure

SEC source: 0001741533-26-000002 · form4-03042026_090352.xml · derivative · entry 5

Paolini John F. · CIK 0001741533 · CHIEF MEDICAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 58,424

Underlying: Class A Ordinary Share · 40,000 shares

Expires 2028-02-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on November 18, 2025.

F5 · derivative.exercise_date: The option is fully vested and exercisable.

Read SEC document
March 02, 2026 Filed Mar 4, 2026 21:40 UTC
Paolini John F.CHIEF MEDICAL OFFICER
SaleClass A Ordinary Share 5,714 $45.92 $262,386.88
Disclosure

SEC source: 0001741533-26-000002 · form4-03042026_090352.xml · nonDerivative · entry 4

Paolini John F. · CIK 0001741533 · CHIEF MEDICAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 61,324

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on November 18, 2025.

F4 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging between $45.56 and $46.09. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.

Read SEC document
March 02, 2026 Filed Mar 4, 2026 21:40 UTC
Paolini John F.CHIEF MEDICAL OFFICER
SaleClass A Ordinary Share 22,223 $44.88 $997,368.24
Disclosure

SEC source: 0001741533-26-000002 · form4-03042026_090352.xml · nonDerivative · entry 3

Paolini John F. · CIK 0001741533 · CHIEF MEDICAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 67,038

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on November 18, 2025.

F3 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging between $44.555 and $45.49. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.

Read SEC document
March 02, 2026 Filed Mar 4, 2026 21:40 UTC
Paolini John F.CHIEF MEDICAL OFFICER
SaleClass A Ordinary Share 12,063 $44.20 $533,184.60
Disclosure

SEC source: 0001741533-26-000002 · form4-03042026_090352.xml · nonDerivative · entry 2

Paolini John F. · CIK 0001741533 · CHIEF MEDICAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 89,261

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on November 18, 2025.

F2 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging between $43.555 and $44.55. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.

Read SEC document
March 02, 2026 Filed Mar 4, 2026 21:40 UTC
Paolini John F.CHIEF MEDICAL OFFICER
Exercise / conversionClass A Ordinary Share 40,000 $10.36 $414,400.00
Disclosure

SEC source: 0001741533-26-000002 · form4-03042026_090352.xml · nonDerivative · entry 1

Paolini John F. · CIK 0001741533 · CHIEF MEDICAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 101,324

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on November 18, 2025.

Read SEC document
February 12, 2026 Filed Feb 12, 2026 21:34 UTC Exercise / conversionShare Option · Derivative 2,690 $0.00 Strike: $15.47 $0.00
Disclosure

SEC source: 0001384243-26-000004 · form4-02122026_090237.xml · derivative · entry 6

Quart Barry D · CIK 0001384243 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Ordinary Shares · 2,690 shares

Expires 2029-05-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 11, 2025.

F2 · derivative.exercise_date: The option is fully vested and exercisable.

Read SEC document
February 12, 2026 Filed Feb 12, 2026 21:34 UTC SaleClass A Ordinary Share 2,690 $45.00 $121,050.00
Disclosure

SEC source: 0001384243-26-000004 · form4-02122026_090237.xml · nonDerivative · entry 4

Quart Barry D · CIK 0001384243 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,546

F1 · kind: This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 11, 2025.

Read SEC document
February 12, 2026 Filed Feb 12, 2026 21:34 UTC Exercise / conversionClass A Ordinary Share 2,690 $15.47 $41,614.30
Disclosure

SEC source: 0001384243-26-000004 · form4-02122026_090237.xml · nonDerivative · entry 3

Quart Barry D · CIK 0001384243 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,236

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 11, 2025.

Read SEC document
February 10, 2026 Filed Feb 12, 2026 21:34 UTC Exercise / conversionShare Option · Derivative 110 $0.00 Strike: $15.47 $0.00
Disclosure

SEC source: 0001384243-26-000004 · form4-02122026_090237.xml · derivative · entry 5

Quart Barry D · CIK 0001384243 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,690

Underlying: Class A Ordinary Shares · 110 shares

Expires 2029-05-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 11, 2025.

F2 · derivative.exercise_date: The option is fully vested and exercisable.

Read SEC document
February 10, 2026 Filed Feb 12, 2026 21:34 UTC SaleClass A Ordinary Share 110 $45.00 $4,950.00
Disclosure

SEC source: 0001384243-26-000004 · form4-02122026_090237.xml · nonDerivative · entry 2

Quart Barry D · CIK 0001384243 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,546

F1 · kind: This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 11, 2025.

Read SEC document
February 10, 2026 Filed Feb 12, 2026 21:34 UTC Exercise / conversionClass A Ordinary Share 110 $15.47 $1,701.70
Disclosure

SEC source: 0001384243-26-000004 · form4-02122026_090237.xml · nonDerivative · entry 1

Quart Barry D · CIK 0001384243 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,656

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 11, 2025.

Read SEC document
February 09, 2026 Filed Feb 11, 2026 21:38 UTC
Ragosa MarkCHIEF FINANCIAL OFFICER
Exercise / conversionShare Option · Derivative 2,471 $0.00 Strike: $16.90 $0.00
Disclosure

SEC source: 0001835458-26-000004 · form4-02112026_090228.xml · derivative · entry 6

Ragosa Mark · CIK 0001835458 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Ordinary Share · 2,471 shares

Expires 2031-04-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on August 14, 2025.

F4 · derivative.exercise_date: The option is fully vested and exercisable.

Read SEC document
February 09, 2026 Filed Feb 11, 2026 21:38 UTC
Ragosa MarkCHIEF FINANCIAL OFFICER
Exercise / conversionShare Option · Derivative 8,374 $0.00 Strike: $12.97 $0.00
Disclosure

SEC source: 0001835458-26-000004 · form4-02112026_090228.xml · derivative · entry 5

Ragosa Mark · CIK 0001835458 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Ordinary Share · 8,374 shares

Expires 2031-09-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on August 14, 2025.

F4 · derivative.exercise_date: The option is fully vested and exercisable.

Read SEC document
February 09, 2026 Filed Feb 11, 2026 21:38 UTC
Ragosa MarkCHIEF FINANCIAL OFFICER
SaleClass A Ordinary Share 8,731 $43.72 $381,719.32
Disclosure

SEC source: 0001835458-26-000004 · form4-02112026_090228.xml · nonDerivative · entry 4

Ragosa Mark · CIK 0001835458 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,086

F1 · kind: This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on August 14, 2025.

F3 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging between $43.35 and $44.18. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff fullinformation regarding the number of Shares sold at each price.

Read SEC document
February 09, 2026 Filed Feb 11, 2026 21:38 UTC
Ragosa MarkCHIEF FINANCIAL OFFICER
SaleClass A Ordinary Share 9,114 $42.85 $390,534.90
Disclosure

SEC source: 0001835458-26-000004 · form4-02112026_090228.xml · nonDerivative · entry 3

Ragosa Mark · CIK 0001835458 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,817

F1 · kind: This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on August 14, 2025.

F2 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging between $42.35 and $43.345. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff fullinformation regarding the number of Shares sold at each price.

Read SEC document
February 09, 2026 Filed Feb 11, 2026 21:38 UTC
Ragosa MarkCHIEF FINANCIAL OFFICER
Exercise / conversionClass A Ordinary Share 2,471 $16.90 $41,759.90
Disclosure

SEC source: 0001835458-26-000004 · form4-02112026_090228.xml · nonDerivative · entry 2

Ragosa Mark · CIK 0001835458 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 29,931

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on August 14, 2025.

Read SEC document
February 09, 2026 Filed Feb 11, 2026 21:38 UTC
Ragosa MarkCHIEF FINANCIAL OFFICER
Exercise / conversionClass A Ordinary Share 8,374 $12.97 $108,610.78
Disclosure

SEC source: 0001835458-26-000004 · form4-02112026_090228.xml · nonDerivative · entry 1

Ragosa Mark · CIK 0001835458 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 27,460

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on August 14, 2025.

Read SEC document
February 04, 2026 Filed Feb 4, 2026 23:24 UTC Exercise / conversionShare Option · Derivative 2,602 $0.00 Strike: $15.47 $0.00
Disclosure

SEC source: 0001384243-26-000002 · form4-02042026_110219.xml · derivative · entry 9

Quart Barry D · CIK 0001384243 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,800

Underlying: Class A Ordinary Shares · 2,602 shares

Expires 2029-05-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 11, 2025.

F5 · derivative.exercise_date: The option is fully vested and exercisable.

Read SEC document
February 04, 2026 Filed Feb 4, 2026 23:24 UTC SaleClass A Ordinary Share 2,602 $45.02 $117,142.04
Disclosure

SEC source: 0001384243-26-000002 · form4-02042026_110219.xml · nonDerivative · entry 6

Quart Barry D · CIK 0001384243 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,546

F1 · kind: This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 11, 2025.

F4 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging between $45.00 and $45.05. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.

Read SEC document
February 04, 2026 Filed Feb 4, 2026 23:24 UTC Exercise / conversionClass A Ordinary Share 2,602 $15.47 $40,252.94
Disclosure

SEC source: 0001384243-26-000002 · form4-02042026_110219.xml · nonDerivative · entry 5

Quart Barry D · CIK 0001384243 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,148

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 11, 2025.

Read SEC document
February 03, 2026 Filed Feb 4, 2026 23:24 UTC Exercise / conversionShare Option · Derivative 12,528 $0.00 Strike: $15.47 $0.00
Disclosure

SEC source: 0001384243-26-000002 · form4-02042026_110219.xml · derivative · entry 8

Quart Barry D · CIK 0001384243 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,402

Underlying: Class A Ordinary Shares · 12,528 shares

Expires 2029-05-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 11, 2025.

F5 · derivative.exercise_date: The option is fully vested and exercisable.

Read SEC document
February 03, 2026 Filed Feb 4, 2026 23:24 UTC SaleClass A Ordinary Share 12,528 $45.27 $567,142.56
Disclosure

SEC source: 0001384243-26-000002 · form4-02042026_110219.xml · nonDerivative · entry 4

Quart Barry D · CIK 0001384243 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,546

F1 · kind: This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 11, 2025.

F3 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging between $45.00 and $45.48. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.

Read SEC document
February 03, 2026 Filed Feb 4, 2026 23:24 UTC Exercise / conversionClass A Ordinary Share 12,528 $15.47 $193,808.16
Disclosure

SEC source: 0001384243-26-000002 · form4-02042026_110219.xml · nonDerivative · entry 3

Quart Barry D · CIK 0001384243 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 25,074

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 11, 2025.

Read SEC document
February 02, 2026 Filed Feb 4, 2026 23:24 UTC Exercise / conversionShare Option · Derivative 830 $0.00 Strike: $15.47 $0.00
Disclosure

SEC source: 0001384243-26-000002 · form4-02042026_110219.xml · derivative · entry 7

Quart Barry D · CIK 0001384243 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,930

Underlying: Class A Ordinary Shares · 830 shares

Expires 2029-05-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 11, 2025.

F5 · derivative.exercise_date: The option is fully vested and exercisable.

Read SEC document
February 02, 2026 Filed Feb 4, 2026 23:24 UTC SaleClass A Ordinary Share 830 $45.00 $37,350.00
Disclosure

SEC source: 0001384243-26-000002 · form4-02042026_110219.xml · nonDerivative · entry 2

Quart Barry D · CIK 0001384243 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,546

F1 · kind: This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 11, 2025.

F2 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging between $45.00 and $45.02. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.

Read SEC document
February 02, 2026 Filed Feb 4, 2026 23:24 UTC Exercise / conversionClass A Ordinary Share 830 $15.47 $12,840.10
Disclosure

SEC source: 0001384243-26-000002 · form4-02042026_110219.xml · nonDerivative · entry 1

Quart Barry D · CIK 0001384243 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,376

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 11, 2025.

Read SEC document
February 01, 2026 Filed Feb 4, 2026 23:20 UTC Exercise / conversionRestricted Share Units · Derivative 683 $0.00 $0.00
Disclosure

SEC source: 0001454983-26-000002 · form4-02042026_110254.xml · derivative · entry 3

Levy Richard S · CIK 0001454983 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Ordinary Shares · 683 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.

F2 · derivative.exercise_date: The RSUs vested immediately upon grant on February 1, 2026; there was no expiration date for the RSUs.

F2 · derivative.expiration_date: The RSUs vested immediately upon grant on February 1, 2026; there was no expiration date for the RSUs.

Read SEC document
February 01, 2026 Filed Feb 4, 2026 23:20 UTC GrantRestricted Share Units · Derivative 683 $0.00 $0.00
Disclosure

SEC source: 0001454983-26-000002 · form4-02042026_110254.xml · derivative · entry 2

Levy Richard S · CIK 0001454983 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 683

Underlying: Class A Ordinary Shares · 683 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.

F2 · derivative.exercise_date: The RSUs vested immediately upon grant on February 1, 2026; there was no expiration date for the RSUs.

F2 · derivative.expiration_date: The RSUs vested immediately upon grant on February 1, 2026; there was no expiration date for the RSUs.

Read SEC document
February 01, 2026 Filed Feb 4, 2026 23:20 UTC Exercise / conversionClass A Ordinary Share 683 Not disclosed Not disclosed
Disclosure

SEC source: 0001454983-26-000002 · form4-02042026_110254.xml · nonDerivative · entry 1

Levy Richard S · CIK 0001454983 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,157

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.

Read SEC document
January 15, 2026 Filed Apr 3, 2026 20:41 UTC
Tessari EbenCHIEF STRATEGY OFFICER
GrantClass A Ordinary Share 365 $24.16 $8,818.40
Disclosure

SEC source: 0001867899-26-000002 · form4-04032026_080412.xml · nonDerivative · entry 1

Tessari Eben · CIK 0001867899 · CHIEF STRATEGY OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,031

F1 · kind: The reporting person is voluntarily reporting the acquisition of these shares pursuant to the Issuer's 2018 Employee Share Purchase Plan for the purchase period of July 16, 2025 to January 15, 2026. The acquisition of these shares was exempt pursuant to Rule 16b-3(e).

Read SEC document
January 15, 2026 Filed Apr 3, 2026 20:35 UTC
Moat RossCHIEF OPERATING OFFICER
GrantClass A Ordinary Share 879 $24.16 $21,236.64
Disclosure

SEC source: 0001857177-26-000002 · form4-04032026_080450.xml · nonDerivative · entry 1

Moat Ross · CIK 0001857177 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,294

F1 · kind: The reporting person is voluntarily reporting the acquisition of these shares pursuant to the Issuer's 2018 Employee Share Purchase Plan for the purchase period of July 16, 2025 to January 15, 2026. The acquisition of these shares was exempt pursuant to Rule 16b-3(e).

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.